Roche AG has become the latest pharmaceutical company to respond to the Trump administration\u2019s threat to impose tariffs, saying it will invest $50 billion in drug and diagnostics manufacturing in the U.S. over the next five years. That figure matches a similar commitment by its Basel, Switzerland-based neighbor, Novartis AG, which on April 11 said it would be investing almost $50 billion in the U.S., also over the next five years.<\/p>\n
BioWorld<\/a> Financings<\/a> Medical technology<\/a> Europe<\/a> Trade<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Roche AG has become the latest pharmaceutical company to respond to the Trump administration\u2019s threat to impose tariffs,…\n","protected":false},"author":2,"featured_media":12793,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[8086,4176,1176,197,9341,9340,9344,9343,228,1078,337,9342,134,4178,112,497],"class_list":{"0":"post-12792","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-bioworld","9":"tag-bioworld-medtech","10":"tag-diagnostics","11":"tag-europe","12":"tag-european-commission","13":"tag-european-federation-of-pharmaceutical-industries-and-associations","14":"tag-financings","15":"tag-fuji-diosynth-biotechnologies","16":"tag-manufacturing","17":"tag-novartis-ag","18":"tag-pharmaceuticals","19":"tag-regeneron-inc","20":"tag-roche","21":"tag-roche-ag","22":"tag-tariffs","23":"tag-trade"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/12792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=12792"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/12792\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/12793"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=12792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=12792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=12792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}